IPath Series Financial Statements From 2010 to 2024
| GRN Etf | USD 27.45 0.45 1.61% |
Market Capitalisation {Big=-, Small=-, Mega=-, Medium=-, Micro=-} |
Check IPath Series financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IPath Series' main balance sheet or income statement drivers, such as , as well as many indicators such as . IPath financial statements analysis is a perfect complement when working with IPath Series Valuation or Volatility modules.
IPath |
iPath Series B ETF Price To Earning Analysis
IPath Series' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current IPath Series Price To Earning | 3.36 X |
Most of IPath Series' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, iPath Series B is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, iPath Series B has a Price To Earning of 3.36 times. This is much higher than that of the Barclays family and significantly higher than that of the Commodities Focused category. The price to earning for all United States etfs is notably lower than that of the firm.
iPath Series B Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IPath Series's current stock value. Our valuation model uses many indicators to compare IPath Series value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IPath Series competition to find correlations between indicators driving IPath Series's intrinsic value. More Info.iPath Series B is one of the top ETFs in price to earning as compared to similar ETFs. It is rated # 4 ETF in beta as compared to similar ETFs totaling about 0.01 of Beta per Price To Earning. The ratio of Price To Earning to Beta for iPath Series B is roughly 84.00 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IPath Series' earnings, one of the primary drivers of an investment's value.About IPath Series Financial Statements
IPath Series investors utilize fundamental indicators, such as revenue or net income, to predict how IPath Etf might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
The index has the objective of providing exposure to the price of carbon as measured by the return of futures contracts on carbon emissions credits from two of the worlds major emissions-related mechanisms. Ipath Series is traded on New York Stock Exchange in the United States.
Pair Trading with IPath Series
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IPath Series position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IPath Series will appreciate offsetting losses from the drop in the long position's value.Moving against IPath Etf
| 0.36 | SLV | iShares Silver Trust | PairCorr |
| 0.36 | SIVR | abrdn Physical Silver | PairCorr |
| 0.35 | GLTR | abrdn Physical Precious | PairCorr |
| 0.31 | GLD | SPDR Gold Shares | PairCorr |
| 0.31 | IAU | iShares Gold Trust | PairCorr |
The ability to find closely correlated positions to IPath Series could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IPath Series when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IPath Series - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling iPath Series B to buy it.
The correlation of IPath Series is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IPath Series moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if iPath Series B moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for IPath Series can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of IPath Series Correlation against competitors. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
The market value of iPath Series B is measured differently than its book value, which is the value of IPath that is recorded on the company's balance sheet. Investors also form their own opinion of IPath Series' value that differs from its market value or its book value, called intrinsic value, which is IPath Series' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IPath Series' market value can be influenced by many factors that don't directly affect IPath Series' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IPath Series' value and its price as these two are different measures arrived at by different means. Investors typically determine if IPath Series is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IPath Series' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.